National Academies Press: OpenBook

Nanotechnology and Oncology: Workshop Summary (2011)

Chapter: 6 Nanotechnology and the Public

« Previous: 5 Standards and Regulation
Suggested Citation:"6 Nanotechnology and the Public." Institute of Medicine. 2011. Nanotechnology and Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13037.
×

6

Nanotechnology and the Public

Several speakers spoke of the need to educate the public and policy makers about nanotechnology’s actual risks and benefits. Dr. Hawk said acquiring public acceptance of nanotechnologies is one of the more pressing challenges to their translation into the clinic. He cited a survey of a Swiss population in which a variety of different unknowns were raised by consumers about foods or food packaging altered by nanotechnology (Siegrist et al., 2007). The questions these consumers raised included do nanoparticles migrate?, what are the downstream environmental impacts of nanoproducts?, and do we properly evaluate their safety?

“The overarching issue of social trust comes into play with acceptance both of the technology as well as appropriate regulatory oversight in the view of the public. Questions around safety play prominently in the minds of the public,” Dr. Hawk said.

Dr. Zhao noted that scientists know more about nanotoxicology than is conveyed to the public and policymakers, and even to people in the nanotechnology community. Many remain unaware of the progress being made in nanotoxicology and instead are likely to believe magnified risks of nanotechnology conveyed to them, he said. “We need to communicate with the public with respect to the safety and ethical concerns. The public is deeply concerned about the directions our society is moving in, and the technologies that are developed,” Dr. Zhao said.

He noted insufficient regulatory oversight of nanotechnologies will reinforce the fears that the public has about the safety of nanoproducts. “If you do not know it, you fear it,” he said, and suggested more

Suggested Citation:"6 Nanotechnology and the Public." Institute of Medicine. 2011. Nanotechnology and Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13037.
×

dialogue with the public to increase awareness and understanding of nanotechnologies, as well as more stringent regulation and oversight of these technologies. Dr. Kulinowski noted that the cosmetic products that FDA does not have premarket approval over are generating much more controversy because there’s a perception that “there’s no one minding the store.” Several nongovernmental organizations have written reports and filed petitions for FDA to take a stronger approach toward these products, she said. “I would argue that concerns over drugs and medical devices are less because there’s a perception that FDA has different, more rigorous process for screening these drugs,” Dr. Kulinowski said.

Dr. Gaspar stressed that it is not just the general public that needs to be educated about nanotechnologies, but also policymakers. “Before you have a problem with the general public, you have a problem with people that are making uninformed decisions,” he said.

Suggested Citation:"6 Nanotechnology and the Public." Institute of Medicine. 2011. Nanotechnology and Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13037.
×
Page 63
Suggested Citation:"6 Nanotechnology and the Public." Institute of Medicine. 2011. Nanotechnology and Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13037.
×
Page 64
Next: 7 Additional Challenges »
Nanotechnology and Oncology: Workshop Summary Get This Book
×
Buy Paperback | $31.00 Buy Ebook | $24.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market.

The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!